UPDATE 2-Eli Lilly to delay new studies as coronavirus puts strain on hospitals

U.S. drugmaker Eli Lilly & Co said on Monday it would delay starting new studies and pause enrolment in ongoing studies, as it looks to free up healthcare facilities and doctors to attend to the growing number of COVID-19 patients.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.